← FDA Drug Approvals (Drugs@FDA)

EXEMESTANE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2018-04-27

Drug application

FDA Application #

ANDA210323

Application type

Abbreviated New Drug Application (Generic)

Brand name

EXEMESTANE

Generic name

EXEMESTANE

Active ingredients

EXEMESTANE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

CIPLA

Manufacturer

Cipla USA Inc.

First approval

2018-04-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown